UCP2 and hepatocellular carcinoma: It can inhibit mitochondrial uncoupling protein 2 (UCP2) to combat oxidative stress and inhibit tumor cell proliferation; additionally, it can be used as a PPARγ agonist to prevent the postoperative recurrence of hepatocellular carcinoma (Wu et al., 2023).